Acquisition Context Steady Health was acquired by Carbon Health in June 2021 for 350M, signaling a shift toward integrated digital diabetes care within a larger health tech platform. This opens opportunities to engage Carbon Health or its subsidiaries for continued collaboration, service expansion, or integration partnerships around CGM-driven care.
CGM Plus Telemedicine Steady combines continuous glucose monitoring data with telemedicine to deliver personalized diabetes care. Sales opportunities exist in offering CGM data integration, remote monitoring workflows, and endocrinologist-driven care management to health systems, employer health programs, and diabetes-focused clinics seeking scalable remote care.
Growth Potential With a small team and revenue in the low millions, Steady appears to be an early-stage platform with room for scale. This indicates a potential fit for partnerships or channel sales with larger digital health platforms seeking to augment diabetes management capabilities or expand into CGM-enabled care.
Strategic Partnerships Existing partnerships with Dexcom and CGM ecosystem players suggest openness to integrations and data interoperability. Target opportunities include CGM manufacturers, payer-sponsored programs, and health system partnerships seeking streamlined data flows and value-based care outcomes.
Market Positioning Steady positions as a first full-service digital diabetes clinic in the US, addressing demand for data-driven, convenient diabetes care. Sales angles include leveraging this differentiator to attract employers, health plans, and care delivery networks aiming to modernize diabetes management and improve engagement.